Articles From: Keppel Unit K1 Ventures to Sell Transportation Leasing Business to Wells Fargo to Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer


By Gaurav Raghuvanshi SINGAPORE--k1 Ventures Ltd.
Sign-up for Keppel Unit K1 Ventures to Sell Transportation Leasing Business to Wells Fargo investment picks
OR YEHUDA, Israel , September 17, 2013 /PRNewswire/ -- Magic Software Enterprises Ltd.
Sign-up for Kerensen Consulting, Cloud Leader in France, Standardizes on Magic xpi Integration Platform for Its salesforce.com Customers investment picks
2014/3/4
http://media.marketwire.com/attachments/201312/209612_marketwire_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1094855&ProfileId=051205&sourceType=1 SUGAR LAND, TX --
Sign-up for Kern County Becoming Renewable Energy Hotspot With 1.4 Gigawatts of Solar Projects, an Industrial Info News Alert investment picks
2013/7/31
Kern County Public Health Services Empowers Residents with Restaurant Inspection Data, Grades and Images to Promote Health Awareness BAKERSFIELD, Calif.
Sign-up for Kern County Residents Keep Tabs on Restaurant Health Inspection Status using Custom AT&T Mobile App investment picks
2014/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0929869001&sourceType=1 http://media3.marketwire.com/logos/20140123-kerr-lg.jpg http://media3.marketwire.com/logos/20140124-BearLake.jpg TORONTO, ONTARIO and LONGUEUIL, QUEBEC --
Sign-up for Kerr Mines and Bear Lake Enter Into Arrangement Agreement investment picks
2014/1/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0923841001&sourceType=1 http://media3.marketwire.com/logos/20140124-BearLake.jpg http://media3.marketwire.com/logos/20140123-kerr-lg.jpg TORONTO, ONTARIO and LONGUEUIL, QUEBEC --
Sign-up for Kerr Mines and Bear Lake Gold Announce Agreement to Combine the Companies investment picks
2014/3/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0935455001&sourceType=1 http://media3.marketwire.com/logos/20140123-kerr-lg.jpg TORONTO, ONTARIO --
Sign-up for Kerr Mines Closes First Tranche of Non-Brokered Private Placement and Announces Proposed Debt Settlements investment picks
2014/4/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0938834001&sourceType=1 http://media3.marketwire.com/logos/20140123-kerr-lg.jpg TORONTO, ONTARIO --
Sign-up for Kerr Seeks Shareholder Consent for Acquisition of Bear Lake investment picks
2014/2/24
Dominant Franchises, Lucrative Business Model, and Adjacent Growth Opportunities Remain Overlooked by the Market NEW YORK , Feb.
Sign-up for Kerrisdale Capital Issues Investment Report on JGWPT Holdings (JGW) investment picks
2014/4/2
Refutes Statements Made by the Current Board in its Recently Issued Press Release Defends its Slate of Highly Qualified Director Nominees NEW YORK , April 2, 2014 /PRNewswire/ -- Kerrisdale Capital Management, LLC ("Kerrisdale"), a private investment management firm and beneficial owner of more than 3% of the shares of Morgans Hotel Group Co.
Sign-up for Kerrisdale Capital Management Delivers Letter To Board Of Morgans Hotel Group investment picks
2014/3/12
Issues Open Letter to Morgans Hotel Group Stockholders NEW YORK , March 12, 2014 /PRNewswire/ -- Kerrisdale Capital Management, LLC ("Kerrisdale"), a private investment management firm and beneficial owner of more than 3% of the shares of Morgans Hotel Group Co.
Sign-up for Kerrisdale Capital Management Nominates A Slate Of Seven Highly Qualified Director Candidates For Election At Morgans Hotel Group's 2014 Annual Meeting investment picks
2014/1/21
NEW YORK, Jan.
Sign-up for Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access investment picks
2014/4/2
NEW YORK, April 2, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced that the European Medicines Agency ("EMA") has determined that the Company's Marketing Authorization Application ("MAA") seeking the approval of Zerenex™ (ferric citrate coordination complex) as a treatment for hyperphosphatemia in patients with chronic kidney disease ("CKD"), including dialysis- and non-dialysis-dependent CKD, is valid.
Sign-up for Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) investment picks
2013/10/8
NEW YORK, Oct.
Sign-up for Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex(TM) New Drug Application investment picks
2014/1/17
Marketing Approval Triggers Milestone Payment to Keryx NEW YORK , Jan.
Sign-up for Keryx Biopharmaceuticals Announces Marketing Approval of Ferric Citrate in Japan investment picks
2014/2/26
NEW YORK, Feb.
Sign-up for Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences investment picks
2014/1/22
NEW YORK , Jan.
Sign-up for Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
2014/3/10
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it has submitted a Marketing Authorization Application ("MAA") to the European Medicines Agency ("EMA"), seeking the approval of Zerenex™ (ferric citrate coordination complex) as a treatment for hyperphosphatemia in patients with chronic kidney disease ("CKD"), including dialysis- and non-dialysis dependent CKD.
Sign-up for Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency investment picks
2014/2/18
NEW YORK, Feb.
Sign-up for Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing investment picks
2013/9/4
NEW YORK, Sept.
Sign-up for Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations investment picks
2013/11/5
Highly Statistically Significant Differences Observed in Serum Phosphorus, TSAT, Ferritin, Hemoglobin and FGF-23 versus Placebo Conference Call to Be Held Today, November 5, 2013, at 8:30 am Eastern Time NEW YORK, Nov.
Sign-up for Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study of Non-Dialysis Dependent Chronic Kidney Disease Patients With Elevated Serum Phosphorus and Iron Deficiency Anemia investment picks
2014/4/9
NEW YORK, April 9, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced that Phase 2 clinical results of Zerenex™ (ferric citrate coordination complex) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with elevated serum phosphorus and iron deficiency anemia has been selected as a Late Breaking oral presentation at the National Kidney Foundation 2014 Spring Clinical Meeting, taking place April 22-26, 2014 in Las Vegas, NV.
Sign-up for Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting investment picks
2014/2/10
NEW YORK CITY, Feb.
Sign-up for Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Keppel Unit K1 Ventures to Sell Transportation Leasing Business to Wells Fargo to Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity